US Crackdown On Foreign Biotech Investment Makes Us Poorer, Not Safer

A new, harsh law passed 400-2 by Congress roils US biotech sector, threatens jobs and innovation

Read the full post on Forbes - Healthcare

Steve Dickman, Contributor